Emodin
- Generic Name
- Emodin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H10O5
- CAS Number
- 518-82-1
- Unique Ingredient Identifier
- KA46RNI6HN
- Background
Emodin has been investigated for the treatment of Polycystic Kidney.
- Associated Conditions
- -
- Associated Therapies
- -
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-12-03
- Last Posted Date
- 2015-03-30
- Lead Sponsor
- Zhi-Hong Liu, M.D.
- Target Recruit Count
- 300
- Registration Number
- NCT00801268
- Locations
- 🇨🇳
Liu ZH, Yao XD,Chen X,Hu YL, Nanjing, Jiangsu, China
🇨🇳Yao Xiaodan, Nanjing, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath